Pharmaceutical

US Border Protection warns pharma of risks with incorrect biologic importation

At the Outsourcing in Clinical Trials Conference, US government personnel advised attendees on the transport of biologics across borders.

Oct 30, 2024 - 04:00
US Border Protection warns pharma of risks with incorrect biologic importation
At the Outsourcing in Clinical Trials Conference, US government personnel advised attendees on the transport of biologics across borders.
Read the original article

Tags:

Previous Article

Bavarian eyes Mpox vaccine label expansion to include toddlers, kickstarts Phase...

Next Article

EC approves AstraZeneca’s Fasenra for EGPA treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Aragen invests $30m in new biologics manufacturing facility in India

Aragen invests $30m in new biologics manufacturing faci...

Oct 31, 2023

STAT+: Vertex gets a win as Colorado board leaves cystic fibrosis drug off a list of unaffordable medicines

STAT+: Vertex gets a win as Colorado board leaves cysti...

Dec 9, 2023

Grit Biotechnology secures funds for development of pipeline programmes

Grit Biotechnology secures funds for development of pip...

Sep 11, 2023